These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8725895)

  • 1. Quantitative 1H and 31P MRS of PCA extracts of postmortem Alzheimer's disease brain.
    Klunk WE; Xu C; Panchalingam K; McClure RJ; Pettegrew JW
    Neurobiol Aging; 1996; 17(3):349-57. PubMed ID: 8725895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy.
    Modrego PJ; Pina MA; Fayed N; Díaz M
    CNS Drugs; 2006; 20(10):867-77. PubMed ID: 16999455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic alterations in postmortem Alzheimer's disease brain are exaggerated by Apo-E4.
    Klunk WE; Panchalingam K; McClure RJ; Stanley JA; Pettegrew JW
    Neurobiol Aging; 1998; 19(6):511-5. PubMed ID: 10192209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered brain high-energy phosphate metabolism in mild Alzheimer's disease: A 3-dimensional
    Rijpma A; van der Graaf M; Meulenbroek O; Olde Rikkert MGM; Heerschap A
    Neuroimage Clin; 2018; 18():254-261. PubMed ID: 29876246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro 31P NMR spectroscopy detects altered phospholipid metabolism in Alzheimer's disease.
    Miatto O; Gonzalez RG; Buonanno F; Growdon JH
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):535-9. PubMed ID: 3791069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
    Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
    Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of magnetic resonance spectra by mole percent: comparison to absolute units.
    Klunk WE; Xu CJ; Panchalingam K; McClure RJ; Pettegrew JW
    Neurobiol Aging; 1994; 15(1):133-40. PubMed ID: 8159259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer's disease: results from a randomized controlled trial.
    Rijpma A; van der Graaf M; Lansbergen MM; Meulenbroek O; Cetinyurek-Yavuz A; Sijben JW; Heerschap A; Olde Rikkert MGM
    Alzheimers Res Ther; 2017 Jul; 9(1):51. PubMed ID: 28747210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain metabolism in Alzheimer disease and vascular dementia assessed by in vivo proton magnetic resonance spectroscopy.
    Herminghaus S; Frölich L; Gorriz C; Pilatus U; Dierks T; Wittsack HJ; Lanfermann H; Maurer K; Zanella FE
    Psychiatry Res; 2003 Jul; 123(3):183-90. PubMed ID: 12928106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance spectroscopy and its application to aging and Alzheimer's disease.
    McClure RJ; Kanfer JN; Panchalingam K; Klunk WE; Pettegrew JW
    Neuroimaging Clin N Am; 1995 Feb; 5(1):69-86. PubMed ID: 7743086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study.
    Huang W; Alexander GE; Chang L; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
    Neurology; 2001 Aug; 57(4):626-32. PubMed ID: 11524470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
    Waragai M; Moriya M; Nojo T
    J Alzheimers Dis; 2017; 60(4):1411-1427. PubMed ID: 28968236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.
    Jones RS; Waldman AD
    Neurol Res; 2004 Jul; 26(5):488-95. PubMed ID: 15265265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study.
    Lin AP; Shic F; Enriquez C; Ross BD
    MAGMA; 2003 Feb; 16(1):29-42. PubMed ID: 12695884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo 31P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia.
    Brown GG; Levine SR; Gorell JM; Pettegrew JW; Gdowski JW; Bueri JA; Helpern JA; Welch KM
    Neurology; 1989 Nov; 39(11):1423-7. PubMed ID: 2812317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased glutamate + glutamine in Alzheimer's disease detected in vivo with (1)H-MRS at 0.5 T.
    Antuono PG; Jones JL; Wang Y; Li SJ
    Neurology; 2001 Mar; 56(6):737-42. PubMed ID: 11274307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate.
    Lyoo IK; Kong SW; Sung SM; Hirashima F; Parow A; Hennen J; Cohen BM; Renshaw PF
    Psychiatry Res; 2003 Jun; 123(2):87-100. PubMed ID: 12850248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.
    Wang H; Tan L; Wang HF; Liu Y; Yin RH; Wang WY; Chang XL; Jiang T; Yu JT
    J Alzheimers Dis; 2015; 46(4):1049-70. PubMed ID: 26402632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: changes after treatment with xanomeline, an M1 selective cholinergic agonist.
    Satlin A; Bodick N; Offen WW; Renshaw PF
    Am J Psychiatry; 1997 Oct; 154(10):1459-61. PubMed ID: 9326834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.